Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis

An increasing number of reports have suggested the use of hydroxychloroquine (HCQ) as an adjunct anti-cancer treatment to enhance the chemotherapeutic response, as well as for the treatment of several fibrotic skin diseases and cystic fibrosis. In this study, we synthesized a cholesterol-modified HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li, Ren, Jun, He, Zhiyao, Men, Ke, Mao, Ye, Ye, Tinghong, Chen, Hua, Li, Ling, Xu, Bocheng, Wei, Yuquan, Wei, Xiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587549/
https://www.ncbi.nlm.nih.gov/pubmed/28878315
http://dx.doi.org/10.1038/s41598-017-11450-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587549/
https://www.ncbi.nlm.nih.gov/pubmed/28878315
http://dx.doi.org/10.1038/s41598-017-11450-3

Ejemplares similares